Introduction
Myxoma is the most common benign cardiac tumor. The incidence was
reported to be 60–80% at the left atrium, 15-28% at the right atrium,
8% at the right ventricle, and 3-4% at the left ventricle. The
atrioventricular valve area was the least common origin (1%) [1,2].
There are several approaches to remove myxoma, including traditional
sternotomy, minimally invasive thoracotomy, and robot-assisted surgery.
Robot-assisted endoscopic operation was done for huge tumor excision and
tricuspid valve (TV) repair. During the operation, the myxoma was
downsized with a morcellator (NOUVAG AG, Inc, Goldach, Switzerland) in
the pericardial cavity. Simultaneous TV repair was completed from the
endoscopic working ports.